Medicaid Drug Coverage

The prescription drug benefit in Texas Medicaid is heavily influenced by pharmaceutical companies, causing higher costs, physician administrative burdens, and delays in access to necessary medications. Allowing managed care organizations to fully manage the Medicaid PDL would improve patient care, save taxpayer dollars, and modernize the Medicaid system.

This implementation has already been delayed 10 years due to pharmaceutical lobbying, and it is crucial that Texas prioritizes the needs of its citizens and the effectiveness of its health care system over protecting pharmaceutical profits. Further delays will harm health outcomes, access to prescription drugs, and efforts to improve patient outcomes, as well as significantly increase Medicaid costs.

States with managed care coordination of drug coverage save 21% compared to states that do not use managed care.

Become a Member

Membership with TAHP is an invaluable tool for integrating, building relationships, exchanging information and best practices, and promoting your services. You will be well-armed with the most timely and accurate information, strong relationships with key Texas leaders, and access to seasoned policy and regulatory experts.